| Edição |
Título |
Arquivo |
| Nº S1 (2022) |
Sroki razvitiya neeffektivnosti ingibitorov FNOα i ikh razlichiya u patsientov s immunovospalitel'nymi zabolevaniyami |
|
|
Nuriakhmetova T., Cheremina N., Abdulganieva D.
|
| Nº 4S (2022): Supplement |
Soluble suppression of tumorigenicity 2 (sST2) in chronic heart failure |
|
|
Kravchenko A., Chernik T., Tokmachev R.
|
| Nº 2 (2017) |
Strategy of management of patients with non-rheumatic valvular heart diseases (before and after surgery) |
|
|
Gendlin G., Yemelina Y., Nikitin I.
|
| Nº S1 (2022) |
Stratifikatsiya serdechno-sosudistogo riska u bol'nykh arterial'noy gipertenziey s sindromom obstruktivnogo apnoe sna i COVID-19 v anamneze |
|
|
Tokarev S., Gubareva I.
|
| Nº S1 (2022) |
Strakh padeniy kak modifitsiruemyy faktor riska padeniy u patsientov s arterial'noy gipertenziey |
|
|
Samkova I., Larina V., Fedorova E., Sirkina O.
|
| Volume 8, Nº 9 (2022) |
Stress and its influence at the cardiovascular system |
|
|
Belyaeva I., Pyokhova Y., Vershinin A.
|
| Volume 8, Nº 8 (2022) |
The structure of the prevalence of cardiovascular diseases and chronic kidney disease in patients with type 2 diabetes mellitus in the stationary care |
|
|
Demidova T., Izmailova M.
|
| Volume 8, Nº 10 (2022) |
Structure of polymorbidities of the digestive diseases in patients receiving direct oral anticoagulants: results of a multicenter cross-sectional pharmacoepidemiological study |
|
|
Ostroumova O., Orlova I., Kochetkov A., Polyakova O., Listratov A., Shatalova N., Batyukina S.
|
| Nº S1 (2022) |
Strukturno-funktsional'nye izmeneniya miokarda u lits s arterial'noy gipertenziey i nalichiem starcheskoy astenii |
|
|
Nikiforov V., Fomina E.
|
| Volume 8, Nº 6 (2022) |
Student medical tournament in Chuvashia - best practices from working with young people of the Russian Scientific Medical Society of Internal Medicine |
|
|
- -.
|
| Volume 9, Nº 5 (2023) |
Subclinical anxiety and depression in young and middle-aged persons: Occurrence, association with cardiac risk factors and multimorbidity |
|
|
Larina V., Glibko K., Arakelov S., Kasaeva D.
|
| Nº 6 (2016) |
Subclinical hypothyroidism - new cardiovascular risk factor |
|
|
Volkova A., Dora S., Berkovich O., Dygun O., Volkova Y., Ostroukhova Y.
|
| Volume 8, Nº 2 (2022) |
RHEUMATOLOGICAL PROBLEMS WITH COVID-19: FROM ARTHRALGIA TO RHEUMATOID ARTHRITIS |
|
|
KARATEEV A.
|
| Nº 1 (2018) |
Dayly dynamics of indices of central aortic pressure and arterial stiffness in patients with arterial hypertension in the composition of a metabolic syndrome at the background of a fixed-dose combination of perindopril arginine and indapamide |
|
|
Andreeva L., Panchenkova L., Martynov A., Troshina E., Khamidova K., Kazanceva E., Medvedeva L., Karnuta G., Yurkova T.
|
| Volume 9, Nº 10 (2023) |
24-hour blood pressure monitoring during treatment with free and fixed combinations of antihypertensive drugs |
|
|
Gumerov F., Mayanskaya S., Malysheva E.
|
| Nº 1 (2017) |
Is there a relationship between bronchial asthma and arterial hypertension? |
|
|
Kuznetsov A., Grigorieva N., Ilyushina T., Mayorova M.
|
| Nº 2 (2017) |
Such different sartans. Place of candesartan |
|
|
Shaposhnik I.
|
| Nº 2 (2016) |
MANAGEMENT OF PATIENT WITH GASTROESOPHAGEAL REFLUX DISEASE |
|
|
YEREMINA Y.
|
| Nº 2 (2015) |
TACTICS OF THERAPY IN ACUTE INTESTINAL INFECTIONS |
|
|
Ploskireva A.
|
| Nº 8 (2017) |
TAURIN IN COMPLEX THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE |
|
|
Teplova N., Abduragimov S., Volov N., Sofrina S., Benevskaya M.
|
| Volume 9, Nº 7 (2023) |
Telemedical technologies in the treatment of obesity as a way of interdisciplinary approach implementation |
|
|
Shestakova E., Lazareva A., Mazurina N., Komshilova K., Ershova E.
|
| Nº 4 (2015) |
THERAPEUTIC PATIENT EDUCATION - AN INTEGRAL ELEMENT OF A COMPREHENSIVE APPROACH TO THE TREATMENT OF DIABETES |
|
|
Valitov B.
|
| Volume 8, Nº 8 (2022) |
Therapy of asthenia in patients after acute novel coronavirus infection (COVID-19): results of a multicenter, randomized, double-blind, placebocontrolled clinical study |
|
|
Ostroumova O., Ebzeeva E., Polyakova O., Gantseva K., Malchikova S., Ershov O., Kamchatnov P., Avdeeva M., Filippov E., Ushakova S., Khamitov R., Beloglazov V., Pyankov A., Grigorovich M., Ezhov A.
|
| Volume 10, Nº 2 (2024) |
Asthenia therapy: time-proven efficiency |
|
|
Frolova V.
|
| Volume 9, Nº 7 (2023) |
Therapy of non-alcoholic liver steatosis as an important factor in the prevention of complications of non-alcoholic fatty liver disease |
|
|
Tarasova L., Tsyganova Y.
|
| Volume 9, Nº 1 (2023) |
Therapy of osteoarthritis in combination with assymptomatic hyperuricemia: results of a pilot study |
|
|
Mazurov V., Bashkinov R., Inamova O., Petrova M., Morozova K.
|
| Volume 8, Nº 3 (2022) |
Therapy of acute respiratory viral infections in outpatient practice during the COVID-19 pandemic |
|
|
Amon E., Esaulenko E., Taganov A., Shiryaeva M., Malinnikova E.
|
| Volume 7, Nº 5 (2021) |
COVID-19 therapy: the efficacy and safety of combination of Ingavirin® with standard recommended treatment in real clinical practice |
|
|
Malyavin A., Krikheli N., Rogova I., Asadulin P., Kucher S., Kharkovsky V.
|
| Nº 7 (2017) |
Treatment of chronic back pain. Current approaches to pain management |
|
|
Kurushina O., Barulin A., Chernovolenko E.
|
| Volume 8, Nº 4 (2022) |
THORNY PATH TO THE DIAGNOSIS OF «AMYLOIDOSIS OF THE HEART» |
|
|
Tarasova L., Dubova A., Dimitrieva O., Khripunova O.
|
| Volume 8, Nº 10 (2022) |
Course of COVID-19-associated pneumonia in patients vaccinated against COVID-19 |
|
|
Lysenko M., Poteshkina N., Ibragimova A., Krylova N., Kovalevskaya E., Karasev A., Svanadze A.
|
| Volume 9, Nº 2 (2023) |
Course of COVID-19-associated pneumonia in patients vaccinated against COVID-19 |
|
|
Lysenko M., Poteshkina N., Ibragimova A., Krylova N., Kovalevskaya E., Karasev A., Svanadze A.
|
| Nº S1 (2022) |
Techenie novoy koronavirusnoy infektsii pri khronicheskoy bolezni pochek |
|
|
Abyzov A., Kichigin V., Chepurnaya O., Oreshnikov E., Oreshnikova S., Abyzov I.
|
| Nº S1 (2022) |
Techenie novoy koronavirusnoy infektsii pri khronicheskoy bolezni pochek |
|
|
Abyzov A., Kichigin V., Chepurnaya O., Oreshnikov E., Oreshnikova S., Abyzov I.
|
| Nº S1 (2022) |
T-kletochnyy i gumoral'nyy otvet na COVID-19 u bol'nykh revmatoidnym artritom |
|
|
Omel'chenko V., Letyagina E., Akimova A., Kurochkina Y., Bratko I., Korolev M.
|
| Nº S1 (2022) |
Tolerantnost' k fizicheskoy nagruzke u bol'nykh tsirrozami pecheni |
|
|
Levitan B., Kas'yanova T., Martynova A.
|
| Volume 8, Nº 2 (2022) |
THICKNESS OF THE INTIMA-MEDIA COMPLEX OF CAROTID ARTERIES IN PATIENTS WITH EXTRASKELETINAL MANIFESTATIONS OF SPONDYLOARTHRITIS |
|
|
REBROV A., APARKINA A., GAMAYUNOVA K.
|
| Volume 7, Nº 10 (2021) |
Topical non-steroidal antiinflammatory medicines in osteoarthritis treatment in patients with concomitant pathology |
|
|
Gaydukova I., Bashkinov A., Inamova O.
|
| Nº 5 (2016) |
Torasemide and furosemide: similarities and differences |
|
|
Cheltsov V.
|
| Volume 8, Nº 7 (2022) |
Tocilizumab, baricitinib, olokizumab and dexamethasone: comparative characteristics and prognosis of efficacy in COVID-19 |
|
|
Sukhomlinova I., Bakulin I., Kabanov M.
|
| Nº S1 (2022) |
Trendy smertnosti, komorbidnosti i lecheniya posle infarkta miokarda u patsientov s revmatoidnym artritom v Stavropol'skom krae |
|
|
Shchendrigin I.
|
| Volume 7, Nº 7 (2021) |
Thrombotic complications in patients with liver cirrosis: current state of the problem |
|
|
Osadchuk A., Osadchuk M., Zolotovskaya I.
|
| Nº S1 (2022) |
Pulmonary embolism after traumatic surgery: is there a connection? Clinical case |
|
|
Khlevchuk N., Komelyagina N., Zhuravleva N., Egorova E., Solovyov A., Gavrilova E.
|
| Volume 8, Nº 10 (2022) |
Pulmonary thromboembolism in a young female patient due to the novel coronavirus infection |
|
|
Larina V., Karpenko D., Serova E., Ryzhikh A., Tyazhelnikov A.
|
| Volume 10, Nº 3 (2024) |
Difficulties of curation of a patient with irritable bowel syndrome |
|
|
Busalaeva E., Tarasova L.
|
| Volume 8, Nº 4 (2022) |
126 DIFFICULTIES OF EARLY DIAGNOSIS OF HEART SARCOMA: CASE FROM PRACTICE |
|
|
Postnikova L., Gudim A., Pasechnik N., Kozyrev S., Troyan V.
|
| Volume 9, Nº 3 (2023) |
Tubulointersticial nephritis |
|
|
Batyushin M., Zakusilov D., Sigitova O.
|
| Volume 8, Nº 9 (2022) |
Severe allergic reactions in the practice of a general practitioner |
|
|
Timofeeva N., Stomenskaya I., Kostrova O., Sergeeva O.
|
| Nº 9S (2022): Supplement |
Uvazhaemye kollegi! |
|
|
Martynov A.
|
| Volume 8, Nº 9 (2022) |
Uvazhaemye kollegi! |
|
|
MARTYNOV M.
|
| Nº 1 (2015) |
Uvazhaemye kollegi! |
|
|
Spasskiy A.
|
| Nº 2 (2015) |
Uvazhaemye kollegi! |
|
|
Lazebnik L.
|
| Nº 4 (2015) |
Uvazhaemye kollegi! |
|
|
Demidova T.
|
| Nº 2 (2016) |
Uvazhaemye kollegi! |
|
|
Lazebnik L.
|
| Nº 3 (2017) |
Uvazhaemye kollegi! |
|
|
Lazebnik L.
|
| Nº 6 (2016) |
Uvazhaemye kollegi! |
|
|
Vertkin A.
|
| Nº 8 (2017) |
Uvazhaemye kollegi! |
|
|
Vertkin A.
|
| Nº 1 (2018) |
Uvazhaemye kollegi! |
|
|
Malyavin A.
|
| Volume 9, Nº 2 (2023) |
Dear Colleagues! |
|
|
Editorial B.
|
| Nº 1 (2015) |
Uvazhaemye kollegi! Dorogie druz'ya! |
|
|
Martynov A.
|
| Nº 4 (2018) |
Uveites as paradoxal reaction or nonefficacy of treatment in ankylosing spondylitis patients, getting inhibitors of alpha tumour necrosis factor |
|
|
Gaidukova I., Samigulina R., Vasilenko E., Inamova O., Gaidukova E., Trophimov E., Mazurov V.
|
| Volume 9, Nº 3 (2023) |
Increasing of glomeral filtration rate in the setting of serum uric acid normalization in high cardiovascular risk patients – clinical observations |
|
|
Gaydukova I., Mazurov V., Inamova O., Tsinzerling A., Bashkinov R.
|
| Volume 10, Nº 4 (2024) |
Shock wave therapy: possibilities and perspectives for application in clinical practice for diabetic foot patients |
|
|
Teltevskaya I., Ivanova S., Yushchuk E., Mkrtumyan A., Melekhina I.
|
| Nº S1 (2022) |
Ul'trazvukovye osobennosti artrita i entezita v zavisimosti ot narusheniya fizicheskogo funktsionirovaniya pri psoriaticheskom artrite |
|
|
Fayrushina I., Kirillova E., Abdulganieva D.
|
| Volume 7, Nº 5 (2021) |
Mild cognitive impairment in clinical practice |
|
|
Bogolepova A.
|
| Volume 9, Nº 7 (2023) |
The COPD exacerbations equation: What do we know about variables? (Literature review) |
|
|
Kostenko D.
|
| Nº S1 (2022) |
Uroven' vitamina D v syvorotke krovi v gruppe patsientov s zabolevaniyami endokrinnoy sistemy |
|
|
Tutynina M., Sapozhnikova I.
|
| Volume 8, Nº 10S (2022): Supplement |
Uroven' kollagena IV tipa u patsientov s yazvennym kolitom |
|
|
Mukhametova D., Abdulganieva D., Zinkevich O., Safina N., Korovina M., Odintsova A.
|
| Nº S1 (2022) |
The level of awareness of beginner district therapists about the management of patients with primary osteoarthritis |
|
|
Bashkova I., Busalaeva E.
|
| Nº S1 (2022) |
Uroven' prokal'tsitonina u bol'nykh s COVID-19 na fone arterial'noy gipertenzii |
|
|
Shuvalova A., Polunina O., Prokof'eva T., Ostroukhova E.
|
| Nº S1 (2022) |
Uroven' S-reaktivnogo proteina u bol'nykh obstruktivnoy bolezn'yu legkikh s razlichnoy vyrazhennost'yu nikotinovoy zavisimosti |
|
|
Prokof'eva T., Novikova N., Polunina O., Sevost'yanova I., Perova N.
|
| Nº S1 (2022) |
Uroven' eozinofilii krovi u patsientov s chastymi obostreniyami khronicheskoy obstruktivnoy bolezni legkikh |
|
|
Zinnatullina A., Khamitov R.
|
| Volume 8, Nº 10 (2022) |
Levels of middle and low molecular weight substances in patients with Q-wave and without Q-wave myocardial infarction associated with chronic obstructive pulmonary disease |
|
|
Prokofieva T., Polunina O., Sevostianova I., Polunina E., Belyakova I., Perova N.
|
| Volume 9, Nº 9 (2023) |
Levels of interleukins 1β, 23, osteoprotegerin, receptor activator of nuclear factor-kappa B ligand in the dynamics of hypoxytherapy performing in female patients with autoimmune thyroiditis |
|
|
Ignatenko G., Maylyan E., Ignatenko T., Lesnichenko D., Valigun Y., Tumanova S.
|
| Volume 7, Nº 6 (2021) |
Levels of apoptosis indicators in patients with myocardial infarction on the background of chronic obstructive pulmonary disease depending on the time of development of myocardial ischemia |
|
|
Naumov A., Prokofieva T., Polunina O., Saroyants L., Lipnitskaya E., Polunina E.
|
| Volume 9, Nº 6 (2023) |
Enhanced external counterpulsation as a measure of non-drug treatment of patients with severe and moderate ventilation disorders |
|
|
Nikolaeva N., Belenkov Y., Lishuta A., Voronkova O., Rogova E., Buyanova O., Abdullaeva G.
|
| Nº S1 (2022) |
Usilennaya naruzhnaya kontrpul'satsiya kak sredstvo reabilitatsii patsientov s tyazhelymi ventilyatsionnymi narusheniyami |
|
|
Nikolaeva N., Voronkova O., Lishuta A.
|
| Nº S1 (2022) |
Faktory, vliyayushchie na kachestvo ratsiona pitaniya patsientov s infarktom miokarda |
|
|
Sedykh D., Petrova T., Khryachkova O., Kashtalap V.
|
| Nº S1 (2022) |
Faktory kardiometabolicheskogo riska i osobennosti klinicheskogo techeniya gipertroficheskoy kardiomiopatii v zavisimosti ot vozrasta manifestatsii klinicheskikh proyavleniy |
|
|
Davydova V., Gudkova A.
|
| Nº S1 (2022) |
Faktory kardiometabolicheskogo riska u molodykh muzhchin pri nealkogol'noy zhirovoy bolezni pecheni |
|
|
Yakovleva S., Pirogova I., Vereina N.
|
| Nº 4S (2022): Supplement |
Pathogenic factors of Helicobacter pylori in patients with coronary heart disease in combination with peptic ulcer |
|
|
Vasilyeva L., Suslova E., Gosteva E.
|
| Volume 10, Nº 5 (2024) |
Risk factors of brain stroke, specific for female individuals |
|
|
Maksimova M., Ayrapetova A.
|
| Nº S1 (2022) |
Faktory riska prekapillyarnoy legochnoy gipertenzii pri professional'noy obstruktivnoy bolezni legkikh u gazoelektrosvarshchikov |
|
|
Artemova L., Rumyantseva O., Komarova S.
|
| Volume 8, Nº 5 (2022) |
Risk factors for the development of adverse outcomes in patients with chronic obstructive pulmonary disease |
|
|
Karoli N., Borodkin A., Rebrov A.
|
| Nº 3 (2018) |
Risk factors for the development of obstructive shock in patients with pulmonary embolism |
|
|
Kochmareva E., Kokorin V., Arefev M., Rusina V., Gordeev I.
|
| Volume 8, Nº 10 (2022) |
Risk factors for the development of various subtypes of gestational diabetes mellitus |
|
|
Volkova N., Davidenko I., Sorokina Y., Degtyareva Y.
|
| Volume 9, Nº 3 (2023) |
Risk factors, prevalence and rates of chronic kidney disease progression in outpatient patients with arterial hypertension |
|
|
Sigitova O., Bogdanova A., Saubanova E.
|
| Nº S1 (2022) |
Faktory, sposobstvuyushchie otkazu ot tabakokureniya, i vidy kognitivnykh iskazheniy u lits s razlichnym statusom kureniya |
|
|
Bezzubtseva M., Demkina A., Lobzhanidze F., Yuldasheva A., Podgorodetskaya N., Aksenova G., Baycharova A., Rublevskaya A., Titova L., Semenova K., Yashchenko E.
|
| Nº S1 (2022) |
Faktory, formiruyushchie priverzhennost' k farmakoterapii u patsientov s khronicheskoy serdechnoy nedostatochnost'yu v period pandemii COVID-19 |
|
|
Leont'eva T., Meshcherina N., Pushkina V.
|
| Volume 8, Nº 4 (2022) |
PHARMACOGENETIC TESTING AS AN ELEMENT OF PERSONALIZED MEDICINE IN REAL CLINICAL PRACTICE |
|
|
Barteneva A., Vorobyeva N.
|
| Nº 4 (2017) |
PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS |
|
|
Nasonov Y.
|
| Nº S1 (2022) |
Farmakoekonomicheskaya otsenka primeneniya genotipirovaniya pri naznachenii dabigatrana u patsientov s fibrillyatsiey predserdiy i khronicheskoy bolezn'yu pochek |
|
|
Mikhaylenko E., Chubarev V., Abdullaev S., Skripka A., Sychev D.
|
| Nº 4S (2022): Supplement |
Pharmacoeconomic evaluation of genotype-guided dabigatran etexilate dosing in patients with atrial fibrillation and chronic kidney disease |
|
|
Mikhaylenko E., Tchubarev V., Abdullaev S., Skripka A., Sychev D.
|
| Volume 10, Nº 1 (2024) |
Pharmacoeconomic analysis of apixaban use for secondary thromboprophylaxis at outpatient stage among oncological patients |
|
|
Kasimova A., Kolbin A.
|
| Volume 8, Nº 4 (2022) |
PHARMACOECONOMIC STUDY OF THE USE OF FOSFOMYCIN AND FLUOROQUINOLONES FOR URINARY TRACT SANITATION IN ORTHOPAEDIC PATIENTS |
|
|
Tufanova O., Kasimova A., Gordina E., Rukina A., Bozhkova S.
|
| Nº 5 (2016) |
Pharmacoepidemiological study of ethnic differences in the use of antihypertensive drugs for hospital treatment of residents of the Karachay-Cherkess Republic |
|
|
Baturin V., Elkanova A.
|
| Volume 10, Nº 5 (2024) |
Febuxostat: efficacy and safety of the drug, prospects for application (literature review) |
|
|
Shchemeleva E., Skorodumova E.
|
| Volume 9, Nº 6 (2023) |
Federal clinical recommendations for sarcoidosis diagnosis and treatment: accents and comments |
|
|
Vizel A., Avdeev S., Malyavin A., Shmelev E., Vizel I.
|
| Nº 5 (2018) |
The phenotype of knee joint osteoarthritis in 60 years old and more patients (results of the multicenter ULA study) |
|
|
Zolotovskaya I., Davydkin I., Grigoryeva N., Tribuntseva L., Volkorezov I.
|
| Volume 7, Nº 6 (2021) |
The phenotype of a patient with COVID-19: the tactics of making a decision on a timely hospitalization |
|
|
Zolotovskaya I., Gimatdinova G., Davydkin I., Sabanova V.
|
| 1201 - 1300 de 1393 resultados |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |
